✦ LIBER ✦

Discontinuation of infliximab and potential predictors of persistent low disease activity in patients with early rheumatoid arthritis and disease activity score-steered therapy: subanalysis of the BeSt study

✍ Scribed by van den Broek, M.; Klarenbeek, N. B.; Dirven, L.; van Schaardenburg, D.; Hulsmans, H. M. J.; Kerstens, P. J. S. M.; Huizinga, T. W. J.; Dijkmans, B. A. C.; Allaart, C. F.

Book ID: 118184634
Publisher: BMJ Publishing Group
Year: 2011
Tongue: English
Weight: 216 KB
Volume: 70
Category: Article
ISSN: 0003-4967
DOI: 10.1136/ard.2010.147751

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Four-year follow-up of infliximab therap

Four-year follow-up of infliximab therapy in rheumatoid arthritis patients with long-standing refractory disease: attrition and long-term evolution of disease activity

✍ Vander Bert Cruyssen, Stijn Van Looy, Bart Wyns… 📂 Article 📅 2006 🏛 BioMed Central 🌐 English ⚖ 448 KB

Improvement in Disease Activity Scores A

Improvement in Disease Activity Scores Associated with Early Versus Late Initiation of Biologic Therapy in Patients with Rheumatoid Arthritis: Results of a European Chart Review Study

✍ Emery, P.; Solem, C.T.; Macahilig, C.P.; Majer, I.M.; Stephens, J.M.; Cappelleri 📂 Article 📅 2013 🏛 John Wiley and Sons 🌐 English ⚖ 58 KB

Failure of low-dose intravenous immunogl

Failure of low-dose intravenous immunoglobulin therapy to suppress disease activity in patients with treatment-refractory rheumatoid arthritis

✍ Keith S. Kanik; Cheryl H. Yarboro; Yaakov Naparstek; Paul H. Plotz; Ronald L. Wi 📂 Article 📅 1996 🏛 John Wiley and Sons 🌐 English ⚖ 262 KB 👁 2 views

Treatment with high-dose (400 mg/kg/ day) intravenous immunoglobulin ( M g ) shows benefit in many autoimmune diseases but is very expensive. Low-dose M g has also been shown to be effective in inhibiting adjuvant arthritis in the rat. This pilot, randomized, double-blind, placebo-controlled trial w

P13 A prospective study of correlation b

P13 A prospective study of correlation between disease activity score (DAS28) and CRP levels in patients with rheumatoid arthritis (RA)

✍ S Ostwal Vikas; J Oak 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 70 KB

Disease activity early in the course of

Disease activity early in the course of treatment predicts response to therapy after one year in rheumatoid arthritis patients

✍ Daniel Aletaha; Julia Funovits; Edward C. Keystone; Josef S. Smolen 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 205 KB 👁 2 views

Markers of B-lymphocyte activation are e

Markers of B-lymphocyte activation are elevated in patients with early rheumatoid arthritis and correlated with disease activity in the ESPOIR cohort

✍ Jacques-Eric Gottenberg, Corinne Miceli-Richard… 📂 Article 📅 2009 🏛 BioMed Central 🌐 English ⚖ 137 KB